Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of June 2026
Becky Berkman @Becky Berkman
Platinum member since January 2017

Location: United States

Gender: Female

Asset investment style: Qualitative fundamental analysis

Market capitalization:

$8,359,340talents

Virtual portfolio value:

$5,209,137talents

Net overall return per annum:

19.00%

AYA current rank order:

#6

Asset investment philosophy:
Becky Berkman trades U.S. stocks with the top #151 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 19,227 +2,108.33% $145,933
BQ Boqii Holding Limited American Depositary Shares representing Class A Ordinary Shares $0.36 $3.36 40,069 +833.33% $120,207
BQ Boqii Holding Limited Class A Ordinary Shares $0.36 $3.36 40,069 +833.33% $120,207
SXTP 60 Degrees Pharmaceuticals Inc. Common Stock $0.15 $1.34 96,260 +793.33% $114,549
VATE INNOVATE Corp. Common Stock $0.53 $4.14 27,243 +681.13% $98,347
ZJYL JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares $24.06 $248.05 392 +930.96% $87,804
SSNT SilverSun Technologies Inc. Common Stock $18.59 $130.48 667 +601.88% $74,631
LGVN Longeveron Inc. Class A Common Stock $3.45 $26.25 2,857 +660.87% $65,140
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 1,010 +589.24% $41,481
FIVN Five9 Inc. Common Stock $16.31 $110.10 431 +575.05% $40,423
Sum $908,722

Top 10 current stock portfolio positions as of June 2026Strategy

Symbol Company Price Position Capitalization
NVCT Nuvectis Pharma Inc. Common Stock $27.87 3,745 $104,373
AMAT Applied Materials Inc. Common Stock $668.00 81 $54,108
TECH Bio-Techne Corp Common Stock $70.70 706 $49,914
TRVI Trevi Therapeutics Inc. Common Stock $18.00 2,582 $46,476
LGND Ligand Pharmaceuticals Incorporated Common Stock $295.92 157 $46,459
ENTG Entegris Inc. Common Stock $176.28 263 $46,361
MHH Mastech Digital Inc Common Stock $7.82 5,879 $45,973
ESTA Establishment Labs Holdings Inc. Common Shares $89.07 516 $45,960
HIMS Hims & Hers Health Inc. Class A Common Stock $32.71 1,396 $45,663
NPO Enpro Inc. Common Stock $380.22 118 $44,865
Sum $530,152

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@Andy Yeh Alpha

Blog+More

OraSure and its subsidiary DNA Genotek specialize in the lean production of home DNA spit tubes.

Monica McNeil

2019-04-01 08:28:00 Monday ET

OraSure and its subsidiary DNA Genotek specialize in the lean production of home DNA spit tubes.

OraSure and its subsidiary DNA Genotek specialize in the lean production of home DNA spit tubes. OraSure extracts core genetic information from microbiome s

+See More

America and China play the game of chicken over trade and technology.

John Fourier

2018-05-01 11:38:00 Tuesday ET

America and China play the game of chicken over trade and technology.

America and China play the game of chicken over trade and technology, whereas, most market observers and economic media commentators hope the Trump team to

+See More

Innovative investment theory and practice

Olivia London

2022-05-15 10:29:00 Sunday ET

Innovative investment theory and practice

Innovative investment theory and practice Corporate investment can be in the form of real tangible investment or intangible investment. The former conce

+See More

Warren Buffett invests in American stocks across energy, transport, and finance etc.

Daphne Basel

2017-07-07 10:33:00 Friday ET

Warren Buffett invests in American stocks across energy, transport, and finance etc.

Warren Buffett invests in American stocks across numerous industries such as energy, air transport, finance, technology, retail provision, and so forth.

+See More

Trump advisor Gary Cohn aims for tax neutrality over the next decade.

Charlene Vos

2017-02-25 06:44:00 Saturday ET

Trump advisor Gary Cohn aims for tax neutrality over the next decade.

As the White House economic director, Gary Cohn suggests that the Trump administration will tackle tax cuts after the administration *repeals and replaces*

+See More

The Economist highlights a trifecta of plausible explanations for better economic fortunes during the current Trump administration.

Chanel Holden

2018-08-27 09:35:00 Monday ET

The Economist highlights a trifecta of plausible explanations for better economic fortunes during the current Trump administration.

President Trump and his Republican senators and supporters praise the recent economic revival of most American counties. The Economist highlights a trifecta

+See More